These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3148513

  • 1. Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies.
    Tura S, Mazza P, Gherlinzoni F, Zinzani PL, Poletti G, Visani G, Lemoli RM, Bandini G, Cavo M, Galieni P.
    Haematologica; 1988; 73(6):503-8. PubMed ID: 3148513
    [No Abstract] [Full Text] [Related]

  • 2. Abbreviated phase I clinical trial of i.v. mitozolomide.
    Joss RA, Ryssel HJ, Bischoff AK, Goldhirsch A, Brunner KW.
    Cancer Treat Rep; 1986 Jun; 70(6):797-8. PubMed ID: 3524827
    [No Abstract] [Full Text] [Related]

  • 3. Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.
    Tura S, Mazza P, Gherlinzoni F, Zinzani PL, Poletti G, Visani G, Lemoli RM, Cavo M, Galieni P, Tassi C.
    Cancer Chemother Pharmacol; 1989 Jun; 23(2):123-5. PubMed ID: 2910510
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of PTT-119 in man.
    Pannuti F, Coppi G, Borella F, Martoni A, Urbano L, Melotti B.
    Chemioterapia; 1988 Apr; 7(2):113-6. PubMed ID: 3396115
    [Abstract] [Full Text] [Related]

  • 5. Bendamustine: a new therapeutic option for hematologic malignancies.
    Cheson BD.
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):631-3. PubMed ID: 18827785
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of malignant lymphoma with Peptichemio. Preliminary communication].
    Uszyński L, Maj S, Pawelski S.
    Acta Haematol Pol; 1974 Sep; 5(2):153-7. PubMed ID: 4599294
    [No Abstract] [Full Text] [Related]

  • 9. Bendamustine: a new look at an old drug.
    Kalaycio M.
    Cancer; 2009 Feb 01; 115(3):473-9. PubMed ID: 19117340
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemia.
    Longeval E, Ganglji D, Stryckmans P, Kenis Y.
    Cancer Chemother Rep; 1975 Feb 01; 59(6):1173-5. PubMed ID: 769961
    [No Abstract] [Full Text] [Related]

  • 13. Bendamustine: rebirth of an old drug.
    Cheson BD, Rummel MJ.
    J Clin Oncol; 2009 Mar 20; 27(9):1492-501. PubMed ID: 19224851
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Beran M, Jeha S, O'Brien S, Estey E, Vitek L, Zurlo MG, Rios MB, Keating M, Kantarjian H.
    Clin Cancer Res; 1997 Dec 20; 3(12 Pt 1):2377-84. PubMed ID: 9815637
    [Abstract] [Full Text] [Related]

  • 16. Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001).
    Hartmann JT, Mayer F, Schleicher J, Horger M, Huober J, Meisinger I, Pintoffl J, Käfer G, Kanz L, Grünwald V, German sarcoma group.
    Cancer; 2007 Aug 15; 110(4):861-6. PubMed ID: 17599772
    [Abstract] [Full Text] [Related]

  • 17. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
    Bremer K.
    J Cancer Res Clin Oncol; 2002 Nov 15; 128(11):603-9. PubMed ID: 12458340
    [Abstract] [Full Text] [Related]

  • 18. Phase II evaluation of phenesterin in patients with advanced ovarian cancer.
    Bloom RE, Polivogianis L, Davis TE, Bennett JM, Horton J.
    Cancer Treat Rep; 1983 Jun 15; 67(6):601-2. PubMed ID: 6861167
    [No Abstract] [Full Text] [Related]

  • 19. [Recent clinical experiences in the treatment of solid tumors with Peptichemio alone or in combination].
    Paparopoli G.
    G Ital Chemioter; 1974 Jun 15; 21(1):33-5. PubMed ID: 4619385
    [No Abstract] [Full Text] [Related]

  • 20. Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas.
    Gherlinzoni F, Mazza P, Zinzani PL, Tura S, Lanza F, Castoldi G, Bellesi G, Rossi Ferrini PL, Mangoni L, Rizzoli V.
    Blut; 1990 Mar 15; 60(3):172-6. PubMed ID: 2317568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.